Art. 1 Regulation (EU) 2020/1043

In forcesince 15 Jul 2020

For the purposes of this Regulation, the following definitions apply:

(1)

‘clinical trial’ means clinical trial as defined in point (a) of Article 2 of Directive 2001/20/EC;

(2)

‘sponsor’ means sponsor as defined in point (e) of Article 2 of Directive 2001/20/EC;

(3)

‘investigational medicinal product’ means investigational medicinal product as defined in point (d) of Article 2 of Directive 2001/20/EC;

(4)

‘medicinal product’ means medicinal product as defined in point 2 of Article 1 of Directive 2001/83/EC;

(5)

‘genetically modified organism’ or ‘GMO’ means genetically modified organism as defined in point (2) of Article 2 of Directive 2001/18/EC.